Australian Clinical Labs Ltd (AU:ACL) has released an update.
Regal Funds Management Pty Ltd has become a substantial holder in Australian Clinical Labs Ltd, acquiring a 7.99% interest which translates to 16,121,238 ordinary shares. This position gives Regal Funds Management the power to control the disposal of these securities. The acquisition makes them a major player in the financial stake of Australian Clinical Labs, signaling potential shifts in the company’s investor landscape.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
